# High Tide Subsidiary NuLeaf Naturals Pursues Participation in U.S. Medicare CBD Pilot > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medicare-cbd-insurance-coverage-policy-pilot/ > **Published:** 2026-04-01T12:08:01-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:32:53-04:00 > **Clinical Summary:** Explore Medicare CBD insurance coverage policy as NuLeaf Naturals joins the pilot program, marking a shift in federal cannabis therapeutics recognition. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic MedicareCbdInsurance CoveragePolicyGeriatrics Why This Matters Medicare’s exploration of CBD coverage represents a significant shift toward federal recognition of cannabis therapeutics for older adults. This pilot could establish precedent for insurance coverage of cannabis medicines, potentially improving access for patients who currently face financial barriers to treatment. Clinical Summary A Medicare pilot program is launching to evaluate CBD coverage, with industry participants like NuLeaf Naturals seeking inclusion. This represents the first federal insurance exploration of [cannabis-derived therapeutics](https://cedclinic.com/cannabis-related-regulatory-documents-dea/) coverage. The pilot’s scope, patient populations, and covered conditions remain undefined in available reporting. Medicare beneficiaries represent a population with high rates of [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), sleep disorders, and other conditions for which patients commonly seek cannabis treatment. Dr. Caplan’s Take “I’m cautiously optimistic about Medicare exploring CBD coverage, but we need clear clinical protocols and quality standards before implementation. The real test will be whether this pilot establishes evidence-based coverage criteria rather than simply opening access without proper medical oversight.” Clinical Perspective 🧠 Clinicians should monitor this pilot’s development for coverage criteria and approved conditions. Patients currently using CBD should maintain documentation of therapeutic response and discuss insurance implications with providers. This development doesn’t change current prescribing considerations but may influence future access patterns for Medicare beneficiaries. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20High%20Tide%20Subsidiary%20NuLeaf%20Naturals%20Pursues%20Participation%20in%20U.S.%20Medicare%20CBD%20...%20%40drcaplan&url=https%3A//hightideinc.com/high-tide-subsidiary-nuleaf-naturals-pursues-participation-in-u-s-medicare-cbd-pilot-launching-today/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//hightideinc.com/high-tide-subsidiary-nuleaf-naturals-pursues-participation-in-u-s-medicare-cbd-pilot-launching-today/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20High%20Tide%20Subsidiary%20NuLeaf%20Naturals%20Pursues%20Participation%20in%20U.S.%20Medicare%20CBD%20...%20--%20via%20%40drcaplan.bsky.social%20https%3A//hightideinc.com/high-tide-subsidiary-nuleaf-naturals-pursues-participation-in-u-s-medicare-cbd-pilot-launching-today/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://hightideinc.com/high-tide-subsidiary-nuleaf-naturals-pursues-participation-in-u-s-medicare-cbd-pilot-launching-today/](https://hightideinc.com/high-tide-subsidiary-nuleaf-naturals-pursues-participation-in-u-s-medicare-cbd-pilot-launching-today/) Table of Contents - [FAQ](#FAQ)[Does Medicare currently cover CBD treatments?](#Does_Medicare_currently_cover_CBD_treatments) - [What policy changes are being considered regarding CBD and Medicare coverage?](#What_policy_changes_are_being_considered_regarding_CBD_and_Medicare_coverage) - [How does insurance coverage for CBD vary across different plans?](#How_does_insurance_coverage_for_CBD_vary_across_different_plans) - [What conditions might warrant CBD coverage under Medicare in the future?](#What_conditions_might_warrant_CBD_coverage_under_Medicare_in_the_future) - [Why is this development considered clinically relevant?](#Why_is_this_development_considered_clinically_relevant) - [Related](#Related) ## FAQ #### Does Medicare currently cover CBD treatments? Currently, Medicare does not cover [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) as they are not FDA-approved prescription medications. This represents a significant gap in coverage for patients who may benefit from CBD treatments for various medical conditions. #### What policy changes are being considered regarding CBD and Medicare coverage? There are emerging policy discussions about potential pathways for CBD coverage under Medicare. These developments are being closely monitored as they could significantly impact [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) to CBD treatments. #### How does insurance coverage for CBD vary across different plans? Insurance coverage for CBD is currently very limited across most plans, including Medicare. Most patients must pay out-of-pocket for [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/), creating financial barriers to access. #### What conditions might warrant CBD coverage under Medicare in the future? Potential conditions that could justify CBD coverage include epilepsy, [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), and other conditions where CBD has shown clinical efficacy. Coverage would likely require FDA approval and demonstrated medical necessity. #### Why is this development considered clinically relevant? This is rated as notable clinical interest because policy changes regarding Medicare CBD coverage could dramatically affect [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) and treatment options. It represents an emerging area that healthcare providers should monitor closely for potential impacts on [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “High Tide Subsidiary NuLeaf Naturals Pursues Participation in U.S. Medicare CBD Pilot …”, “url”: “https://hightideinc.com/high-tide-subsidiary-nuleaf-naturals-pursues-participation-in-u-s-medicare-cbd-pilot-launching-today/”, “datePublished”: “2026-04-01T12:26:17Z”, “about”: “high tide subsidiary nuleaf naturals pursues”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [CMS unveils new Medicare pilot for hemp, CBD products – Fierce Healthcare](https://cedclinic.com/medicare-pilot-hemp-cbd-coverage-expands-access/) Learn about CMS's new Medicare pilot program focusing on hemp and CBD products, highlighting federal efforts to expand coverage. [Read More](https://cedclinic.com/medicare-pilot-hemp-cbd-coverage-expands-access/) Medicare Hemp Program Moves Forward Despite Litigation – CRB Monitor News Stay informed on the progress and challenges of the Medicare hemp program amid ongoing legal disputes. Explore Details [Feds Finalize New Rule Allowing Some Hemp Products As Medicare Advantage Benefits](https://cedclinic.com/medicare-hemp-coverage-rule-expands-benefits/) Discover the finalized federal rule permitting certain hemp products as Medicare Advantage benefits, expanding patient options. [Learn More](https://cedclinic.com/medicare-hemp-coverage-rule-expands-benefits/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).